These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33229966)

  • 1. A Narrative Review of Clinical Treatment Outcomes of Neisseria gonorrhoeae Infection With Ciprofloxacin by Minimum Inhibitory Concentration and Anatomic Site.
    Chaudry AE; Klausner JD
    Sex Transm Dis; 2021 Jun; 48(6):385-392. PubMed ID: 33229966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
    Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
    Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Susceptibility of Urogenital and Extragenital Neisseria gonorrhoeae Isolates Among Men Who Have Sex With Men: Strengthening the US Response to Resistant Gonorrhea and Enhanced Gonococcal Isolate Surveillance Project, 2018 to 2019.
    Quilter LAS; St Cyr SB; Hong J; Asbel L; Bautista I; Carter B; Casimir Y; Denny M; Ervin M; Gomez R; Harvey A; Holderman JL; Johnson K; Kohn RP; Learner ER; Mauk K; Menza T; Mettenbrink C; Nettleton WD; Nicosia KR; Pham CD; Ried C; Schlanger K; Schneider A; Soge OO; Tabidze I; Taylor SN; Tilghman W; Toler C; Weinstock H; Torrone EA
    Sex Transm Dis; 2021 Dec; 48(12S Suppl 2):S111-S117. PubMed ID: 34475363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
    Nokchan N; Wongsurawat T; Jenjaroenpun P; Nitayanon P; Tribuddharat C
    PLoS One; 2022; 17(7):e0271657. PubMed ID: 35905043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi.
    Matoga M; Chen JS; Krysiak R; Ndalama B; Massa C; Bonongwe N; Mathiya E; Kamtambe B; Jere E; Chikaonda T; Golparian D; Unemo M; Cohen MS; Hobbs MM; Hoffman IF
    Sex Transm Dis; 2022 Apr; 49(4):251-256. PubMed ID: 34772893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility testing and molecular characterization of
    Zolfaghari P; Emamie AD; Rajabpour M; Zarei A; Whiley DM; Pourmand MR; Pourmand G
    Int J STD AIDS; 2022 Jun; 33(7):660-665. PubMed ID: 35485393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines.
    Knapp JS; Mesola VP; Neal SW; Wi TE; Tuazon C; Manalastas R; Perine PL; Whittington WL
    Sex Transm Dis; 1997 Jan; 24(1):2-7. PubMed ID: 9018776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.
    Pond MJ; Hall CL; Miari VF; Cole M; Laing KG; Jagatia H; Harding-Esch E; Monahan IM; Planche T; Hinds J; Ison CA; Chisholm S; Butcher PD; Sadiq ST
    J Antimicrob Chemother; 2016 Apr; 71(4):897-902. PubMed ID: 26817487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.
    Klausner JD; Bristow CC; Soge OO; Shahkolahi A; Waymer T; Bolan RK; Philip SS; Asbel LE; Taylor SN; Mena LA; Goldstein DA; Powell JA; Wierzbicki MR; Morris SR
    Clin Infect Dis; 2021 Jul; 73(2):298-303. PubMed ID: 32766725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020.
    Al-Maslamani M; Elmagboul EBI; Puthiyottil A; Chemaitelly H; Varghese MK; Al Romaihi HE; Al-Thani MH; Al Khal A; Unemo M; Abu-Raddad LJ
    PLoS One; 2022; 17(3):e0264737. PubMed ID: 35235608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.
    Kirkcaldy RD; Zaidi A; Hook EW; Holmes KK; Soge O; del Rio C; Hall G; Papp J; Bolan G; Weinstock HS
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):321-8. PubMed ID: 23460055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996-2001.
    Zheng HP; Cao WL; Wu XZ; Yang LG
    Sex Transm Infect; 2003 Oct; 79(5):399-402. PubMed ID: 14573836
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
    Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India.
    Sethi S; Sharma D; Mehta SD; Singh B; Smriti M; Kumar B; Sharma M
    Indian J Med Res; 2006 May; 123(5):707-10. PubMed ID: 16873916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
    Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
    Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonococcal susceptibility to antimicrobials in Baltimore, 1988-1994. What was the impact of ciprofloxacin as first-line therapy for gonorrhea?
    Zenilman JM
    Sex Transm Dis; 1996; 23(3):213-8. PubMed ID: 8724511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones.
    Fox KK; Knapp JS; Holmes KK; Hook EW; Judson FN; Thompson SE; Washington JA; Whittington WL
    J Infect Dis; 1997 Jun; 175(6):1396-403. PubMed ID: 9180179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy.
    Dan M; Poch F; Sheinberg B
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1671-3. PubMed ID: 12019074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.